Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes

Iranian Journal of Allergy, Asthma and Immunology

Volumn 8, Issue 1, 2009, Pages 1-9

  Shen, Yan ^a   Kan, Quan Cheng ^a   Xu, Wei ^a   Chu, Yi Wei ^b   Xiong, Si Dong ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Chemokine; Expression profile; Pathogenesis; Viral myocarditis

Indexed keywords

CHEMOKINE; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL13 CHEMOKINE; CXCL14 CHEMOKINE; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5; RANTES; STROMAL CELL DERIVED FACTOR 1; CCL2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; HEART MUSCLE CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VIRUS MYOCARDITIS; ANIMAL; CELL CULTURE; ENTEROVIRUS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HEART; HEART MUSCLE; METABOLISM; MYOCARDITIS; PHYSIOLOGY; UPREGULATION; VIROLOGY;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINES; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; MYOCARDIUM; MYOCYTES, CARDIAC; UP-REGULATION;

EID: 69249211220     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Esfandiarei M, McManus BM. Molecular Biology and Pathogenesis of Viral Myocarditis. Annu Rev Pathol 2008; 3:127-55.
2. Crocker SJ, Frausto RF, Whitmire JK, Benning N, Milner R, Whitton JL. Amelioration of coxsackievirus B3-mediated myocarditis by inhibition of tissue inhibitors of matrix metalloproteinase-1. Am J Pathol 2007; 171(6):1762-73.
3. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, et al. Enteroviral protease 2A cleaves dystrohpin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999; 5(3):320-6.
4. Maier R, Krebs P, Ludewig B. Immunopathological basis of virus-induced myocarditis. Clin Dev Immunol 2004; 11(1):1-5.
5. Fairweather D, Frisancho-Kiss S, Njoku DB, Nyland JF, Kaya Z, Yusung SA, et al. Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1beta, and immune complex deposition in the heart. J Immunol 2006; 176(6):3516-24.
6. Huber S. T cells in coxsackievirus-induced myocarditis. Viral Immunol 2004; 17(2):152-64.
7. Garrood T, Lee L, Pitzalis C. Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways. Rheumatology (Oxford) 2006; 45(3):250-60.
8. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354(6):610-21.
9. Zlotnic A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12(2):121-5.
10. Gerard C and Rollins BJ. Chemokines and diseases. Nature Immunology 2001; 2(2):108-15.
11. Michael, H, Watson KA, Selinka HC, Carthy CM, Klingel K, Mcmanus BM, et al. Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J Virol 1999; 73(5):3587-94.
12. Henke A, Huber SA, Stelzner A, Whitton JL. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 1995; 69(11):6720-8.
13. Huber SA, Sartini D, Exley M. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. J Virol 2002; 76(21):10785-90.
14. Matsumori A. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide. Jpn Circ J 1997; 61(4):275-91.
15. Huber SA. Autoimmunity in coxsackievirus B3 induced myocarditis. Autoimmunity 2006; 39(1):55-61.
16. Huber SA, Sartini D. Roles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis. J Virol 2005; 79(5):2659-65.
17. Liu P, Aitken K, Kong YY, Opavsky MA, Martino T, Dawood F, et al. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nat Med 2000; 6(4):429-34.
18. Taylor LA, Carthy CM, Yang D, Saad K, Wong D, Schreiner G, et al. Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays. Circ Res 2000; 87(4):328-34.
19. Aly M, Wiltshire S, Chahrour G, Osti JC, Vidal SM. Complex genetic control of host susceptibility to coxsackievirus B3-induced myocarditis. Genes Immun 2007; 8(3):193-204.
20. Selinka HC, Wolde A, Sauter M, Kandolf R, Klingel K. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism. Med Microbiol Immunol 2004; 193(2-3):127-31.
21. Huber S, Song WC, Sartini D. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis. Viral Immunol 2006; 19(2):156-66.
22. Luo H, Yanagawa B, Zhang J, Luo Z, Zhang M, Esfandiarei M, Carthy C, et al. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol 2002; 76(7):3365-73.
23. Si X, Luo H, Morgan A, Zhang J, Wong J, Yuan J, et al. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release. J Virol 2005; 79(22):13875-81.
24. Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, et al. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal 2006; 18(5):688-703.
25. Mahabeleshwar GH, Das R, Kundu GC. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways. J Biol Chem 2004; 279(11):9733-42.
26. Damianova R, Stefanova N, Cukierman E, Momchilova A, Pankov R. Three-dimensional matrix induces sustained activation of ERK1/2 via Src/Ras/Raf signaling pathway. Cell Biol Int 2008; 32(2):229-34.
27. Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C, Petric C, et al. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 2002; 109(12):1561-9.